A thorough evaluation of your cardiovascular and metabolic health, including:

• Complete cardiovascular risk stratification using ACC/AHA guidelines

• Assessment of women-specific risk factors (menopause timing, pregnancy history, PCOS)

• Advanced lipid analysis including lipoprotein(a)

• Metabolic health evaluation (insulin resistance, prediabetes screening)

• Body composition assessment

• Personalized risk reduction plan

Evidence-based management of:

• Elevated cholesterol and triglycerides

• Prediabetes and insulin resistance

• Metabolic syndrome

• Statin therapy and alternatives

• Lifestyle intervention strategies
  

Integration of menopause physiology into cardiovascular risk assessment:

• Evaluation of menopause timing and its impact on heart health

• Assessment of vasomotor symptoms and their cardiovascular implications

• Hormone therapy decision-making within a cardiovascular risk framework

• Non-hormonal alternatives for symptom management

• Coordination with gynecology when needed
  

For appropriate candidates, evidence-based prescribing and monitoring of GLP-1 receptor agonist medications:

• Comprehensive evaluation for candidacy

• Structured titration protocols

• Ongoing monitoring and side effect management

• Integration with lifestyle intervention FDA-approved medications only (no compounded products)
  

A structured approach to preserving metabolic health through the menopause transition:

• Targeted nutrition strategy (Mediterranean/DASH patterns)

• Exercise programming with emphasis on resistance training

• Muscle mass preservation strategies

• Sleep optimization

• Stress management